Which nonimmunological biological examinations are necessary to eliminate infectious origin or microcrystalline in early inflammatory arthritis without clinical signs?

Revue du Rhumatisme (Edition Francaise)

Volumn 69, Issue 2, 2002, Pages 162-169

  Schaeverbeke, Thierry ^a   Sibilia, Jean ^b   Fautrel, Bruno ^c  

^a HÔPITAL PELLEGRIN   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Biology; Early arthritis; Serology; Synovial fluid

Indexed keywords

ANTISTREPTOLYSIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA B27 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 8; LACTOFERRIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ARTICLE; BACTERIAL ARTHRITIS; BACTERIUM CULTURE; CAMPYLOBACTER JEJUNI; CHLAMYDIA TRACHOMATIS; CLINICAL FEATURE; CRYSTAL; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; GOUT; HUMAN; IMMUNOFLUORESCENCE; INFECTION; MEDICAL EXAMINATION; MEDICAL LITERATURE; MEDLINE; PROGNOSIS; REACTIVE ARTHRITIS; RHEUMATIC FEVER; SERODIAGNOSIS; SEROLOGY; STREPTOLYSIN TITER; SYNOVIAL FLUID; UREAPLASMA UREALYTICUM;

EID: 0036187142     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(01)00277-0     Document Type: Short Survey

References (54)

1. Critical reading of medical periodicals. II. Judging the value of a diagnostic test
2. Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers
3. The non-immune inflammatory response: Serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protien
4. A prospective 2-year study of 75 patients with adult-onset septic arthritis
5. The usefulness of C-reactive protein levels in the identification of concurrent septic arthritis in children who have acute hematogenous osteomyelitis. A comparison with the usefulness of the erythrocyte and the white blood-cell count
6. Negative C-reactive protein in children with bacterial infection
7. C-reactive protein: A marker for disease activity in ankylosing spondylitis and Reiter's syndrome
8. The value of C-reactive protein measurement in rheumatoid arthritis
9. Lactoferrin and the inflammatory response
10. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease
11. Lactoferrin and lysozyme levels in synovial fluid: Differential indices of articular inflammation and degradation
12. Cytidine deaminase and lactoferrin in inflammatory synovial fluids. Indicators of local polymorphonuclear cell function?
13. CRP levels in autoimmune disease can be specified by measurement of procalcitonin
14. Diagnosis value of serum and synovial procalcitonin in bacterial, cyrstal-associated and rheumatoid arthritis
15. Routine analysis of synovial fluid cells is of value in the differential diagnosis of arthritis in children
16. Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever
17. Jones Criteria (revised) for guidance in the diagnosis of rheumatic fever
18. The diagnostic value of streptococcal serology in early arthritis: A prospective cohort study
19. Rheumatic fever: A multicenter study in the state of Sao Paulo. Pediatric Committee-Sao Paulo Pediatric Rheumatology Society
20. The determination of specific IgA-antibodies to Yersinia enterocolitica and their role in enteric infections and their complications
21. Salmonella reactive arthritis: Serum and secretory antibodies in eight patients identified after a large outbreak
22. Reactive arthritis after Campylobacter jejuni enteritis
23. HLA-B27-negative arthritis related to Campylobacter jejuni enteritis in three children and two adults
24. Reactive arthritis after Campylobacter jejuni enteritis. A case report
25. The value of specific antibody detection and culture in the diagnosis of reactive arthritis
26. Early antibiotic treatment of reactive arthritis associated with enteric infections: Clinical and serological study
27. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicenter, double-blind, randomized, placebo-controlled study
28. Antibiotic trials in reactive arthritis
29. What is the role of mycoplasmas in human inflammatory rheumatic disorders?
30. Comparison of urine, first and second endourethral swabs for PCR based detection of genital Chlamydia trachomatis infection in male patients
31. PCR testing of genital and urine specimens compared with culture for the diagnosis of chlamydial infection in men and women
32. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population
33. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis
34. Serologic diagnosis of Lyme disease
35. Diagnosis of Lyme disease. Current difficulties and prospects
36. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis
37. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens
38. Western blotting in the serodiagnosis of Lyme disease
39. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato
40. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay
41. Rational diagnosis and treatment in unclassified arthritis: How clinical data may guide requests for Lyme serology and antibiotic treatment
42. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis
43. Serum uric acid levels and gout: What does this herald for the population?
44. Soluble urate in sera and synovial fluids from patients with different joint disorders
45. Serum urate during bouts of acute goutry arthritis
46. Serum uric acid in acute gout
47. Crystal-induced arthritis: An overview
48. Crystal identification in human synovial fluids. Methods and interpretation
49. Gout update: From lab to the clinic and back
50. Synovial fluid analysis for diagnosis of intercritical gout
51. Most calcium pyrophosphate crystals appear as non-birefringent
52. Crystals in arthritis: New age nonsense or novel therapeutic target?
53. Monarthritis: Differential diagnosis
54. Laboratory diagnosis of monarthritis: How much, what for, when?